Skip to main content

Yanguang Cao, PhD, is a UNC Lineberger Comprehensive Cancer Center member interested in developing system pharmacology platforms (models) integrating PK/PD to facilitate drug development and optimize therapeutics for cancers and autoimmune diseases.

PhD
Assistant Professor, UNC Eshelman School of Pharmacy
Adjunct Assistant Professor at SUNY Buffalo, Division of Pharmacotherapy and Experimental Therapeutics
UNC-Chapel Hill
Molecular Therapeutics

Area of Interest

  • Pharmacokinetics and pharmacodynamics
  • Tumor resistance
  • Tumor evolution

Awards and Honors

  • NIH MIRA grant – outstanding young investigators

Find publications on PubMed